What does it mean to develop an HIV vaccine by rational design?

Area of Science:

• Immunology
• Vaccinology
• Structural Biology

Background:

• For decades, vaccine research has been guided by principles of design, rationality, and reductionism.
• These principles were applied with the aim of developing an effective Human Immunodeficiency Virus (HIV) vaccine.

Purpose of the Study:

• To critically evaluate the influence of design, rationality, and reductionism on the challenges faced in HIV vaccine development.
• To identify how these guiding concepts may have inadvertently contributed to the lack of an effective HIV vaccine.

Main Methods:

• Review of established concepts in vaccine research and their application to HIV.
• Analysis of structural biology findings, particularly crystallographic studies of antibody-epitope interactions.
• Examination of the distinction between chemical antigenicity and biological immunogenicity.

Main Results:

• The strategy of rationally designing immunogens based on structural data of HIV epitopes failed.
• This failure stemmed from misunderstanding that observed structures result from induced fit, not pre-existing states of free molecules.
• Reductionist thinking led to an overemphasis on chemical antigenicity, neglecting biological immunogenicity and immune system components.

Conclusions:

• The concepts of design, rationality, and reductionism, while influential, were insufficient for developing an effective HIV vaccine.
• A shift in perspective is needed to understand the biological intricacies of immune responses beyond simple structural complementarity.
• Future HIV vaccine strategies must consider the inherent constituents of immune systems that control protective antibody induction.